ENTPD1 and neoplasm: Moreover, CD39 is overexpressed by several types of cancer cells, in addition to tumor-infiltrating T cells, suggesting that CD39 and purinergic signaling can directly modulate tumor growth, metastasis and angiogenesis, in addition to inducing immune tolerance, further favoring cancer progression [40].